New drug aims to curb impulsive behavior in opioid addiction

NCT ID NCT06628622

First seen Nov 01, 2025 · Last updated May 08, 2026 · Updated 22 times

Summary

This study tests whether an experimental medicine called BI 1356225 can help people with opioid use disorder (addiction) control their impulses. About 60 adults aged 18-65 who are already taking buprenorphine will either receive the study drug or a placebo daily for 8 days. Researchers will measure impulsivity using computer tasks and questionnaires to see if the drug improves decision-making.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPIOID-USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Collaborative Neuroscience Research, LLC, Los Alamitos

    RECRUITING

    Los Alamitos, California, 90720, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hassman Research Institute-Marlton-66897

    RECRUITING

    Marlton, New Jersey, 08053, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of California Los Angeles

    RECRUITING

    Los Angeles, California, 90095, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Virginia Commonwealth University

    RECRUITING

    Richmond, Virginia, 23298, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • iResearch Atlanta

    RECRUITING

    Decatur, Georgia, 30030, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.